End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.16 CNY | +0.96% | 0.00% | -5.67% |
04-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-5.67% | 1.09B | |
+29.61% | 682B | |
+30.35% | 586B | |
-3.62% | 364B | |
+17.71% | 327B | |
+3.85% | 285B | |
+15.74% | 240B | |
+10.32% | 209B | |
-8.38% | 203B | |
+7.12% | 165B |
- Stock Market
- Equities
- 600664 Stock
- News Harbin Pharmaceutical Group Co., Ltd.
- Harbin Pharmaceutical Group's Cefotiam Hydrochloride Selected for China's Centralized Procurement Bid